PBAC Recommends PBS Listing for Wegovy
18 Mar 2026
The update follows a request from Mark Butler in 2025 to ensure fair access to obesity treatments through the PBS.
PBAC recommends a “slow and managed” rollout to make sure these medicines are used safely and by the right patients. Priority groups include:
-
People with cardiovascular disease
-
Aboriginal and Torres Strait Islander patients with obesity-related conditions
-
Those with syndromic or medication-induced obesity
-
Patients who need weight loss before surgery
Terri-Lynne South from RACGP welcomed the decision, saying it’s a first step toward more affordable obesity treatments.
She noted price remains the biggest barrier for patients, and GPs should prepare for questions as only a small number of patients will qualify under current PBS rules.
The Government has confirmed it is negotiating the final PBS listing and pricing with the manufacturer, but a public listing could still take months.
https://www1.racgp.org.au/
Source: (RACGP), newsGP